Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in pregnant women with refractory obstetric antiphospholipid syndrome (OAPS-IVIG study)
jRCTs031180116Completed
- Sponsor
- Japan Blood Products Organization
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of immune globulin in antiphospholipid syndrome (APS), sponsored by Japan Blood Products Organization. Primary endpoint: Live birth rate after 30 weeks of gestation. Started Aug 2015; status: completed.
02
Drugs
immune globulin
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on jRCTs031180116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180116.